Am J Respir Crit Care Med

1. EDDY RL, Sin DD
   Loss of Lung Function Led to Loss of Life During the COVID-19 Pandemic.
   Am J Respir Crit Care Med. 2025.
   

   >> Share

   
   

   
   Ann Intern Med

2. JACOBS JW, Booth GS, Lewis-Newby M, Saifee NH, et al
   Medical, Societal, and Ethical Considerations for Directed Blood Donation in 2025.
   Ann Intern Med. 2025 May 13. doi: 10.7326/ANNALS-25-00815.
   

   >> Share

   
   

   
   BMJ

3. WISE J
   Covid-19: Attitudes shifted after politicians broke rules, report says.
   BMJ. 2025;389:r960.
   

   >> Share

   
   

   
   Br J Anaesth

4. COPLEY S, Carty S, Brown M, Mishra S, et al
   Bridging the GAP: a critical analysis of pain management services in the United Kingdom.
   Br J Anaesth. 2025;134:1597-1602.
   

   >> Share

   
   

   
   Clin Infect Dis

5. HAWKINS KL, Dandachi D, Verzani Z, Brannock MD, et al
   HIV Infection and Long COVID: A RECOVER Program, Electronic Health Record Based Cohort Study.
   Clin Infect Dis. 2025 May 12:ciaf242. doi: 10.1093.
   

   >> Share

   
   
6. KONOPNICKI D, Gilles C, Manigart Y, Barlow P, et al
   Immunogenicity and safety of two versus three doses of 9-valent vaccine against Human papillomavirus (HPV) in women with HIV: the Papillon randomized trial.
   Clin Infect Dis. 2025 May 13:ciaf241. doi: 10.1093.
   

   >> Share

   
   
7. VALENCIA D, Edwards L, Horter L, Turner H, et al
   "I Didn't Know Him Before the Pandemic... Now He's on My Speed Dial": Strengthening Collaboration Between Infectious Diseases Physicians and State and Local Public Health for Future Public Health Emergencies.
   Clin Infect Dis. 2025 May 13:ciaf179. doi: 10.1093.
   

   >> Share

   
   
8. AMARIN JZ, Toepfer AP, Spieker AJ, Hayek H, et al
   Respiratory Syncytial Virus Co-Detection With Other Respiratory Viruses Is Not Significantly Associated With Worse Clinical Outcomes Among Children Aged <2 Years: New Vaccine Surveillance Network, 2016-2020.
   Clin Infect Dis. 2025 May 9:ciaf194. doi: 10.1093.
   

   >> Share

   
   

   
   Emerg Infect Dis

9. MACCANNELL D, MacInnis B, Santibanez S, Honein MA, et al
   A Decade of Partnerships and Progress in Pathogen Genomics in Public Health Practice.
   Emerg Infect Dis. 2025;31:1-2.
   

   >> Share

   
   
10. MOORE J, Sanon R, Khudyakov Y, Barnes N, et al
    Strategies and Opportunities to Improve Community Health through Advanced Molecular Detection and Genomic Surveillance of Infectious Diseases.
    Emerg Infect Dis. 2025;31:9-13.
    

    >> Share

    
    
11. FLOREK KR, Young EL, Incekara K, Libuit KG, et al
    Advantages of Software Containerization in Public Health Infectious Disease Genomic Surveillance.
    Emerg Infect Dis. 2025;31:18-21.
    

    >> Share

    
    
12. PORTER WT, Engelthaler DM, Hepp CM
    Genomic Epidemiology for Estimating Pathogen Burden in a Population.
    Emerg Infect Dis. 2025;31:22-24.
    

    >> Share

    
    
13. JULES E, Decker C, Bixler BJ, Ahmed A, et al
    Respiratory Virus Detection and Sequencing from SARS-CoV-2-Negative Rapid Antigen Tests.
    Emerg Infect Dis. 2025;31:39-44.
    

    >> Share

    
    
14. FRIEDMAN CR, Morfino RC, Ernst ET
    Leveraging a Strategic Public-Private Partnership to Launch an Airport-Based Pathogen Monitoring Program to Detect Emerging Health Threats.
    Emerg Infect Dis. 2025;31:35-38.
    

    >> Share

    
    
15. EMMEN IE, Vuyk WC, Lail AJ, Wolf S, et al
    SARS-CoV-2 Genomic Surveillance from Community-Distributed Rapid Antigen Tests, Wisconsin, USA.
    Emerg Infect Dis. 2025;31:61-69.
    

    >> Share

    
    
16. FEISTEL DJ, Welsh R, Mercante J, Mark-Carew M, et al
    Detection and Tracking of SARS-CoV-2 Lineages through National Wastewater Surveillance System Pathogen Genomics.
    Emerg Infect Dis. 2025;31:57-60.
    

    >> Share

    
    
17. PHAM K, Chaguza C, Lopes R, Cohen T, et al
    Large-Scale Genomic Analysis of SARS-CoV-2 Omicron BA.5 Emergence, United States.
    Emerg Infect Dis. 2025;31:45-56.
    

    >> Share

    
    

    
    Infect Control Hosp Epidemiol

18. BROWN MARUSIAK A, Sickbert-Bennett E, Babcock H, Westreich D, et al
    Characterizing presenteeism among healthcare personnel at an academic medical center across eras of the COVID-19 pandemic.
    Infect Control Hosp Epidemiol. 2025 May 16:1-9. doi: 10.1017/ice.2025.
    

    >> Share

    
    
19. STERN RA, Bashaw K, Talbot TR
    Isolating the burden of transmission-based precautions for COVID-19: walk-in clinic-based healthcare personnel perspectives.
    Infect Control Hosp Epidemiol. 2025 May 16:1-2. doi: 10.1017/ice.2025.
    

    >> Share

    
    

    
    Int J Infect Dis

20. INZAULE S, Silva R, Thwin SS, Waasila J, et al
    In-hospital Mortality Among Children and Adults Hospitalized with COVID-19 in Africa Across Pre-Delta, Delta, and Omicron SARS-CoV-2 Waves.
    Int J Infect Dis. 2025 May 7:107924. doi: 10.1016/j.ijid.2025.107924.
    

    >> Share

    
    

    
    J Infect

21. GAO Y, Zhang J, Liu M, Bu Q, et al
    Superior antiviral efficacy of combined 3CL protease and RdRp inhibition compared to 3CL protease inhibitor monotherapy in hospitalized COVID-19 patients.
    J Infect. 2025;90:106502.
    

    >> Share

    
    
22. HOOG M, Westrhenen ESH, Winkel AM, Jong MD, et al
    Impact of co-infection with SARS-CoV-2 and other respiratory viruses on illness: Pooled analyses of 11 COVID-19 cohorts.
    J Infect. 2025 May 9:106501. doi: 10.1016/j.jinf.2025.106501.
    

    >> Share

    
    
23. PETER RS, Sedelmaier L, Nieters A, Brockmann SO, et al
    Symptom burden and post-COVID-19 syndrome 24 months following SARS-CoV-2 infection: Longitudinal population-based study.
    J Infect. 2025;90:106500.
    

    >> Share

    
    

    
    J Med Virol

24. WU Z, Fan S, Xu H, Feng F, et al
    Identifying Neurological Autoantibodies in COVID-19: mGluR2 as a Marker of Immune Dysregulation During the Omicron Outbreak in China.
    J Med Virol. 2025;97:e70381.
    

    >> Share

    
    
25. HABEEBUR-RAHMAN SP, Khan FAA, Mohd-Azlan J, Gumal M, et al
    Comparative Analysis of Quan and Watanabe Pan-Coronavirus Assays for Bat Coronavirus Diversity in Sarawak, East Malaysia.
    J Med Virol. 2025;97:e70389.
    

    >> Share

    
    

    
    J Virol

26. LV L, Luo H, Yi J, Zhang K, et al
    IFITM proteins are key entry factors for porcine epidemic diarrhea coronavirus.
    J Virol. 2025 May 12:e0202824. doi: 10.1128/jvi.02028.
    

    >> Share

    
    
27. FRIEDLANDER AM
    Early short-course treatment fails to prevent disease or relapse upon discontinuance of treatment in infections in addition to COVID-19.
    J Virol. 2025 May 12:e0038125. doi: 10.1128/jvi.00381.
    

    >> Share

    
    
28. KONDO T, Suzuki R, Yajima H, Kawahara S, et al
    Determinants of susceptibility to SARS-CoV-2 infection in murine ACE2.
    J Virol. 2025 May 12:e0054325. doi: 10.1128/jvi.00543.
    

    >> Share

    
    
29. FURUSAWA Y, Iwatsuki-Horimoto K, Yamayoshi S, Kawaoka Y, et al
    The NSP6-L260F substitution in SARS-CoV-2 BQ.1.1 and XBB.1.16 lineages compensates for the reduced viral polymerase activity caused by mutations in NSP13 and NSP14.
    J Virol. 2025 May 13:e0065625. doi: 10.1128/jvi.00656.
    

    >> Share

    
    
30. BROADBENT A
    A veterinary virapalooza: a summary of the 2024 American Society for Virology (ASV) Veterinary/Zoonotic Virology Satellite Symposium and online H5N1 panel discussion.
    J Virol. 2025 May 13:e0049925. doi: 10.1128/jvi.00499.
    

    >> Share

    
    

    
    Lancet Infect Dis

31. SAADATIAN-ELAHI M, Rabilloud M, Mohlmann TWR, Langlois-Jacques C, et al
    Effectiveness of integrated vector management on the incidence of dengue in urban Malaysia: a cluster-randomised controlled trial.
    Lancet Infect Dis. 2025 May 12:S1473-3099(25)00086.
    

    >> Share

    
    

    
    Science

32. CORNWALL W
    With Trump's cuts escalating, 'fear factor' silences researchers.
    Science. 2025;388:684-685.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share